Indian drugmakers Glenmark, Granules India, Sun Pharma, Zydus, and Unichem are recalling various products in the US market due to manufacturing issues. These include CGMP deviations, failed impurity specifications, and label mix-ups, leading to Class I, II, and III recalls initiated from late August to mid-September. The USFDA reported these voluntary actions.